Furthermore, Kato et al. showed that CD44v stabilizes xCT leading to reduced oxidative stress (reviewed in27), whereas xCT inhibition leads to increased cellular ROS levels and suppresses tumor growth25. The gene discussed is SLC7A11; the disease is neoplasm.